ground breaking tech for brain tumour treatment
ZAP-X, a gyroscopic radiosurgery platform, was launched by Apollo Hospitals in Delhi, India this week ( March 11, 2024). It is a first in South Asia for this ground -breaking technology which heralds a new era in brain tumour treatment. It offers patients a non-invasive, pain-free alternative with sessions lasting just 30 minutes.
With minimal radiation exposure, this transformative technology sets new standards for precision and patient comfort. Unlike conventional methods, ZAP-X utilizes a self-shielded, gyroscopic linear accelerator design to accurately focus radiosurgical beams from thousands of angles on the targeted tumour or area.
This translates to shorter treatment times of no more than 30 minutes and allows patients to go home the same day, rather than undergoing traditional brain surgeries that can last 3-4 hours and require extended hospitalization and anesthesia.
With its high success rate of over 95% control in 10 years and an exceptional 99.4% control rate in 5 years for small, defined tumours, ZAP-X is proven to effectively manage various conditions with minimal side effects. Neurologists and neurosurgeons can rely on this technology to achieve precise treatment with fewer risks for their patients.
Dr Prathap Chandra Reddy, Founder Chairman, Apollo Hospitals Group said, “For four decades, Apollo Hospitals has pioneered healthcare, advancing exceptional care. We pledge to democratise technology, making it accessible to all citizens and global communities, elevating standards of brain tumour treatment and ensuring better quality of life. ZAP-X strengthens the battle against non-communicable diseases, especially cancers with superior outcomes.”
Prof. John R. Adler, Founder and CEO, Zap Surgical and Professor of Neurosurgery, Stanford School of Medicine said, “Stereotactic radiosurgery is among the most important medical advancements of the past century. Eligible patients no longer must experience debilitating surgical resections, or potentially lose cognitive capacity by undergoing whole-brain radiotherapy. Instead, with ZAP-X radiosurgery, patients can now be quickly treated in an outpatient setting and often return to normal activities the same day with no incisions, and no pain.”
The Apollo Institute of Neurosciences pioneers neurological care in India and beyond, boasting advanced facilities and over 180,000 successful neurosurgeries. With smart technology, stroke protocols are revolutionised for faster, precise treatment. Supported by 300+ specialists, Apollo treats 25,000 patients annually. The unveiling of the ZAP-X platform reaffirms Apollo’s commitment to spearheading innovations that transform lives.
Apollo Hospitals is the nation’s first corporate hospital in India and established by Dr. Prathap C Reddy in 1983. It is a leading healthcare provider in Asia, with a strong presence in different sectors of the healthcare industry. This includes hospitals, pharmacies, primary care and diagnostic clinics, as well as various retail health models.
Apollo Hospital Delhi
The group also offers telemedicine services in multiple countries and has health insurance services, global projects consultancy, medical colleges, Medvarsity for e-learning, colleges of nursing and hospital management, and a research foundation. Their offerings also include ‘ASK Apollo,’ an online consultation portal, and Apollo Home Health for seamless care.
Apollo’s legacy is built upon its unwavering dedication to exceptional healthcare, accessible prices, advanced technology, and progressive research and education. As one of the pioneers in utilising technology for efficient medical services, Apollo Hospitals was at the forefront of this innovation globally. Embracing the rapid progress in medical equipment worldwide, it has introduced numerous groundbreaking advancements to India including South East Asia’s inaugural Proton Therapy Centre -Apollo Centre in Chennai, India.
Source & Pics: Apollo Hospitals India